Wednesday, May 21, 2025 · SEC filings
What the smart money revealed on May 21
597 insider filings came in. We hid 66 planned (10b5-1) sellers and 382 people whose filings were routine, like grants and tax withholding.
Trimas (TRS) Director Shawn Sedaghat bought $9.16M
359,357 shares on the open market. Not a grant or an option exercise.
Global Indemnity Group (GBLI) Director Saul Fox bought $635K
20,000 shares on the open market. Not a grant or an option exercise.
BlueLinx (BXC) SVP Christopher Wall bought $289K
4,100 shares on the open market. Not a grant or an option exercise.
Pebblebrook Hotel Trust (PEB) Chairman and CEO Jon Bortz bought $226K
23,213 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.
V2X (VVX) Director Dino Cusumano sold $96.8M
Not marked as a planned 10b5-1 sale. Sold 15% of the shares they held directly. Still holds 11.7M shares.
Vulcan Materials (VMC) Chairman and CEO J. Thomas Hill sold $24.1M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 7,421 shares directly.
Exponent (EXPO) Group Vice President Bradley James sold $214K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 45 more real buys
Show 77 more real sales
13F season
Holdings as of Mar 31, 2025 were due May 15
92 funds have filed. 80 filed for the quarter before.
Biggest real insider buys, May 15–21
Open-market buys by officers and directors, filed in the 7 days up to May 21.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.